Suramin ( DrugBank: Suramin )


1 disease
IDDisease name (Link within this page)Number of trials
331Idiopathic multicentric castleman disease1

331. Idiopathic multicentric castleman disease


Clinical trials : 33 Drugs : 46 - (DrugBank : 25) / Drug target genes : 31 - Drug target pathways : 155
No.TrialIDDate_
enrollment
Date_
registration
Public_titleScientific_titleConditionInterventionPrimary_
sponsor
Secondary_
sponsor
Recruitment_
Status
Inclusion_
agemin
Inclusion_
agemax
Inclusion_
gender
Target_
size
PhaseCountries
1NCT00002652
(ClinicalTrials.gov)
May 19951/11/1999Suramin in Treating Patients With Refractory or Relapsed Multiple Myeloma or Castleman's DiseaseA PHASE II PILOT STUDY OF SURAMIN IN PREVIOUSLY TREATED PATIENTS WITH MULTIPLE MYELOMA AND PATIENTS WITH CASTLEMAN'S DISEASEMultiple Myeloma and Plasma Cell NeoplasmDrug: suraminUniversity of ArkansasNational Cancer Institute (NCI)Completed18 YearsN/ABothPhase 2United States